SiNtx Technologies Inc (SINT)

[boston745]

mrinvestorpro
9m
@BroadOne no it means a sale or partnership. They have $15 per share in cash. Not including their patents, technology or clients. They sell for $15+ you triple your money. Get a partner and u could get 10x your money on a run with that tiny float.

BroadOne = PitK17. Guess he decided to change his avatar for some reason. This MrInvestorPro makes good points except they do not have $15 per share in cash unfortunately. ~$6m in Cash end of Q1 with a burn of about $2.8m a quarter means they have about $6m cash at the beginning of Q3 after the funds raised in Q2 offerings. Thus $6m cash and OS of 750k thats $8 per share with a current stock price of $5.07 or so. Stockholders equity is about $13.00 per share right now. Stockholders equity does not factor in the value of Sintx IP. Hell its accumulated deficit is worth $300 per share right now.

I dont think they are looking to sell the entire company but could sell off an asset. Id rather a partnership or sell off Armor to NP Aerospace with licensing revenue. Regardless you can bet the hedge funds that are trying to acquire Sintx through hostile means will look to sabotage any such deals.

https://stocktwits.com/mrinvestorpro/message/580096417

========================================

Section 2 - A conspiracy of shorting and distorting.

This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174693152

This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175

According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174725108

========================================

Section 3 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm